• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗核基质蛋白2抗体阳性皮肌炎复发伴先前脂膜炎

Anti-nuclear Matrix Protein 2 Antibody-Positive Dermatomyositis Relapse With Preceding Panniculitis.

作者信息

Taguchi Hirokazu, Ueda Yoshitaka, Shigehara Yohya, Yokogawa Naoto

机构信息

Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Fuchu, JPN.

Department of Dermatology, Tokyo Metropolitan Tama Medical Center, Fuchu, JPN.

出版信息

Cureus. 2025 Feb 6;17(2):e78622. doi: 10.7759/cureus.78622. eCollection 2025 Feb.

DOI:10.7759/cureus.78622
PMID:40062018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11890021/
Abstract

Dermatomyositis (DM) is an idiopathic inflammatory myopathy characterized by cutaneous lesions such as heliotrope rash, Gottron's papules, and Gottron's sign. Panniculitis is rarely reported as a skin manifestation of DM. Herein, we present a case of anti-nuclear matrix protein 2 antibody (NXP-2)-positive DM relapse with panniculitis in the absence of muscle symptoms. A 32-year-old female patient was referred to our department. Nine years ago, she was diagnosed with DM and had received prednisolone (PSL) and tacrolimus therapy. However, she discontinued her visits four years ago. She most recently presented with erythematous lesions on the right thigh and buttocks without any muscle symptoms. Thirteen days later, she experienced upper limb weakness. Laboratory findings at her current presentation demonstrated elevated serum creatine kinase levels and positivity for anti-NXP-2 antibody. A skin biopsy of the erythema on her left thigh demonstrated findings consistent with healed panniculitis. Based on these findings, an anti-NXP-2 antibody-positive DM relapse was diagnosed. Her symptoms resolved with PSL and tacrolimus therapy. It is important to recognize that panniculitis is a significant, cutaneous manifestation of DM and can present as the initial manifestation of a DM relapse even in the absence of muscle symptoms.

摘要

皮肌炎(DM)是一种特发性炎性肌病,其特征为出现如向阳疹、Gottron丘疹和Gottron征等皮肤病变。脂膜炎作为DM的皮肤表现鲜有报道。在此,我们报告一例抗核基质蛋白2抗体(NXP-2)阳性的DM复发患者,该患者出现脂膜炎且无肌肉症状。一名32岁女性患者转诊至我科。9年前,她被诊断为DM,并接受了泼尼松龙(PSL)和他克莫司治疗。然而,4年前她停止了复诊。她最近一次就诊时右大腿和臀部出现红斑性病变,无任何肌肉症状。13天后,她出现上肢无力。此次就诊时的实验室检查结果显示血清肌酸激酶水平升高且抗NXP-2抗体呈阳性。对其左大腿红斑进行皮肤活检,结果符合愈合性脂膜炎。基于这些发现,诊断为抗NXP-2抗体阳性的DM复发。经PSL和他克莫司治疗后,她的症状得到缓解。认识到脂膜炎是DM的一种重要皮肤表现,即使在无肌肉症状的情况下也可作为DM复发的初始表现,这一点很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/270e/11890021/d6ccfee8c26e/cureus-0017-00000078622-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/270e/11890021/4685e04fc6ad/cureus-0017-00000078622-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/270e/11890021/a1c940df5072/cureus-0017-00000078622-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/270e/11890021/3539d6e28ee9/cureus-0017-00000078622-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/270e/11890021/405cf09e9fb1/cureus-0017-00000078622-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/270e/11890021/d6ccfee8c26e/cureus-0017-00000078622-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/270e/11890021/4685e04fc6ad/cureus-0017-00000078622-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/270e/11890021/a1c940df5072/cureus-0017-00000078622-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/270e/11890021/3539d6e28ee9/cureus-0017-00000078622-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/270e/11890021/405cf09e9fb1/cureus-0017-00000078622-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/270e/11890021/d6ccfee8c26e/cureus-0017-00000078622-i05.jpg

相似文献

1
Anti-nuclear Matrix Protein 2 Antibody-Positive Dermatomyositis Relapse With Preceding Panniculitis.抗核基质蛋白2抗体阳性皮肌炎复发伴先前脂膜炎
Cureus. 2025 Feb 6;17(2):e78622. doi: 10.7759/cureus.78622. eCollection 2025 Feb.
2
A Case of Juvenile Dermatomyositis Presenting with Inverse Gottron's Papules: A Case Report.以反向Gottron丘疹为表现的青少年皮肌炎1例:病例报告
Case Rep Dermatol. 2025 Mar 11;17(1):80-85. doi: 10.1159/000544816. eCollection 2025 Jan-Dec.
3
Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.副肿瘤性皮肌炎伴转移性胃癌患者。
Acta Dermatovenerol Croat. 2020 Aug;28(2):120-122.
4
Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population.抗 NXP-2 抗体阳性的炎性肌病的临床特征及印度人群的预后。
Clin Rheumatol. 2023 Dec;42(12):3289-3297. doi: 10.1007/s10067-023-06751-0. Epub 2023 Oct 6.
5
Anti-MDA5 Antibody-Positive Dermatomyositis Presenting with Cellulitis-Like Erythema on the Mandible as an Initial Symptom.以颌部蜂窝织炎样红斑为首发症状的抗MDA5抗体阳性皮肌炎
Case Rep Dermatol. 2018 May 4;10(2):110-114. doi: 10.1159/000488077. eCollection 2018 May-Aug.
6
Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.皮肌炎的皮肤表现:关键临床和血清学特征——全面综述
Clin Rev Allergy Immunol. 2016 Dec;51(3):293-302. doi: 10.1007/s12016-015-8496-5.
7
[Juvenile-onset anti-nuclear matrix protein 2 (NXP-2) antibody-positive dermatomyositis with joint contractures before manifestation of myositis: a case report].[幼年型抗核基质蛋白2(NXP - 2)抗体阳性皮肌炎在肌炎表现前出现关节挛缩:一例报告]
Rinsho Shinkeigaku. 2024 Jun 27;64(6):417-421. doi: 10.5692/clinicalneurol.cn-001970. Epub 2024 May 25.
8
Panniculitis as an Initial Presentation of Dermatomyositis: A Case Report.脂膜炎为皮肌炎的首发表现:一例报告。
JNMA J Nepal Med Assoc. 2020 Mar;58(223):181-184. doi: 10.31729/jnma.4827.
9
A Case of Dermatomyositis with Coexistence of Positive Anti-MDA5 Antibodies and Anti-SSA/RO52 Antibodies, Combined with Necrotic Skin Ulcers.1例皮肌炎合并抗MDA5抗体和抗SSA/RO52抗体阳性及坏死性皮肤溃疡
Int Med Case Rep J. 2024 Jan 6;17:9-15. doi: 10.2147/IMCRJ.S441691. eCollection 2024.
10
Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report.抗 SAE 自身抗体阳性的日本幼年型皮肌炎合并间质性肺病患者-病例报告。
Pediatr Rheumatol Online J. 2021 Mar 19;19(1):34. doi: 10.1186/s12969-021-00532-2.

本文引用的文献

1
Panniculitis in dermatomyositis: A systematic review of the clinicopathologic features.皮肌炎中的脂膜炎:临床病理特征的系统评价
JAAD Int. 2024 Mar 22;18:50-61. doi: 10.1016/j.jdin.2024.03.004. eCollection 2025 Feb.
2
Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care.幼年特发性关节炎:病理生理学和临床治疗的最新进展。
Nat Rev Rheumatol. 2023 Jun;19(6):343-362. doi: 10.1038/s41584-023-00967-9. Epub 2023 May 15.
3
Subcutaneous tissue involvement in idiopathic inflammatory myopathies: Systematic literature review including three new cases and hypothetical mechanisms.
特发性炎性肌病中的皮下组织受累:系统文献综述,包括三例新病例及假说机制
Autoimmun Rev. 2023 Apr;22(4):103284. doi: 10.1016/j.autrev.2023.103284. Epub 2023 Feb 1.
4
Calcinosis cutis with amyopathic dermatomyositis.无肌病性皮肌炎伴皮肤钙质沉着症。
QJM. 2022 Sep 22;115(9):613-614. doi: 10.1093/qjmed/hcac148.
5
Clinical Heterogeneity of Patients With Antinuclear Matrix Protein 2 Antibody-Positive Myositis: A Retrospective Cohort Study in China.抗核基质蛋白 2 抗体阳性肌炎患者的临床异质性:中国的一项回顾性队列研究。
J Rheumatol. 2022 Aug;49(8):922-928. doi: 10.3899/jrheum.211234. Epub 2022 Jun 15.
6
Dermatomyositis: Clinical features and pathogenesis.皮肌炎:临床特征与发病机制。
J Am Acad Dermatol. 2020 Feb;82(2):267-281. doi: 10.1016/j.jaad.2019.06.1309. Epub 2019 Jul 4.
7
Dermatomyositis panniculitis: a clinicopathological and immunohistochemical study of 18 cases.皮肌炎脂膜炎:18 例临床病理及免疫组化研究。
J Eur Acad Dermatol Venereol. 2018 Aug;32(8):1352-1359. doi: 10.1111/jdv.14932. Epub 2018 Mar 27.
8
The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline.脂肪营养不良综合征的诊断与管理:多学会实践指南
J Clin Endocrinol Metab. 2016 Dec;101(12):4500-4511. doi: 10.1210/jc.2016-2466. Epub 2016 Oct 6.
9
Recurrent lipoatrophic panniculitis of children.儿童复发性脂肪萎缩性脂膜炎
J Eur Acad Dermatol Venereol. 2017 Mar;31(3):536-543. doi: 10.1111/jdv.13858. Epub 2016 Aug 12.
10
Anti-MDA5 antibodies in a large Mediterranean population of adults with dermatomyositis.抗 MDA5 抗体在一个大型地中海地区成年皮肌炎人群中的存在。
J Immunol Res. 2014;2014:290797. doi: 10.1155/2014/290797. Epub 2014 Feb 4.